From CBC News:
Drugs prescribed to treat attention deficit hyperactivity disorder will include guides in the United States to alert patients and parents to the risks of mental and heart problems, including sudden death.
The U.S. Food and Drug Administration said Wednesday that it directed the manufacturers of Ritalin, Adderall, Strattera and all other ADHD drugs to develop the guides. ...more
Friday, February 23, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment